La Jolla Pharmaceutical Shares Outstanding 2006-2018 | LJPC

La Jolla Pharmaceutical shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
La Jolla Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2018 25
2017 21
2016 17
2015 16
2014 11
2013 2
2012 0
2011 0
2010 0
2009 63
2008 50
2007 38
2006 33
2005 15
La Jolla Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 25
Q3 2018 26
Q2 2018 26
Q1 2018 23
Q4 2017 21
Q3 2017 22
Q2 2017 22
Q1 2017 18
Q4 2016 17
Q3 2016 17
Q2 2016 17
Q1 2016 17
Q4 2015 16
Q3 2015 15
Q2 2015 15
Q1 2015 15
Q4 2014 11
Q3 2014 14
Q2 2014 8
Q1 2014 6
Q4 2013 2
Q3 2013 1
Q2 2013 1
Q1 2013 0
Q4 2012 0
Q3 2012 0
Q2 2012 0
Q1 2012 109
Q4 2011 0
Q3 2011 0
Q2 2011 11
Q1 2011 0
Q4 2010 0
Q3 2010 0
Q2 2010 0
Q1 2010 0
Q4 2009 63
Q3 2009 66
Q2 2009 66
Q1 2009 56
Q4 2008 50
Q3 2008 55
Q2 2008 48
Q1 2008 40
Q4 2007 38
Q3 2007 40
Q2 2007 39
Q1 2007 33
Q4 2006 33
Q3 2006 33
Q2 2006 33
Q1 2006 32
Q4 2005 15
Q3 2005 15
Q2 2005 15
Q1 2005 14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.207B $0.010B
LA JOLLA PHARMACEUTICAL CO. is engaged in the research and development of therapeutic products for the treatment of autoimmune and inflammatory diseases.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.398B 30.86
Takeda Pharmaceutical (TAK) Japan $33.153B 12.27
Grifols (GRFS) Spain $13.201B 16.00
Ionis Pharmaceuticals (IONS) United States $10.870B 34.75
Jazz Pharmaceuticals (JAZZ) Ireland $7.800B 11.17
Neurocrine Biosciences (NBIX) United States $7.664B 496.41
Sage Therapeutics (SAGE) United States $7.450B 0.00
Tilray (TLRY) United States $6.754B 0.00
Nektar Therapeutics (NKTR) United States $6.186B 9.87
Catalent (CTLT) United States $6.146B 25.73
United Therapeutics (UTHR) United States $5.149B 8.76
FibroGen (FGEN) United States $4.834B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.238B 13.64
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.164B 0.00
Portola Pharmaceuticals (PTLA) United States $2.224B 0.00
Zogenix (ZGNX) United States $2.190B 0.00
USANA Health Sciences (USNA) United States $2.146B 18.01
Aerie Pharmaceuticals (AERI) United States $2.135B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.134B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.106B 0.00
PTC Therapeutics (PTCT) United States $2.103B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.968B 24.51
Endo (ENDP) Ireland $1.894B 2.92
Heron Therapeutics (HRTX) United States $1.853B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.754B 0.00
Xencor (XNCR) United States $1.688B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.592B 137.93
Corcept Therapeutics (CORT) United States $1.396B 20.28
Esperion Therapeutics (ESPR) United States $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.317B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.276B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.108B 0.00
Tricida (TCDA) United States $1.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.888B 0.00
Radius Health (RDUS) United States $0.854B 0.00
Odonate Therapeutics (ODT) United States $0.635B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.566B 0.00
Forty Seven (FTSV) United States $0.552B 0.00
GlycoMimetics (GLYC) United States $0.522B 0.00
ChemoCentryx (CCXI) United States $0.515B 0.00
ArQule (ARQL) United States $0.510B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.504B 29.73
Siga Technologies (SIGA) United States $0.503B 0.00
KalVista Pharmaceuticals (KALV) United States $0.499B 0.00
Akebia Therapeutics (AKBA) United States $0.466B 0.00
Flexion Therapeutics (FLXN) United States $0.456B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.431B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.405B 0.00
TCR2 THERAPTCS (TCRR) United States $0.402B 0.00
ImmunoGen (IMGN) United States $0.396B 0.00
Concert Pharmaceuticals (CNCE) United States $0.388B 0.00
OptiNose (OPTN) United States $0.376B 0.00
Translate Bio (TBIO) United States $0.375B 0.00
Aptorum Group (APM) China $0.373B 0.00
Majesco Entertainment (PTE) United States $0.335B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.332B 0.00
Minerva Neurosciences (NERV) United States $0.322B 0.00
Lannett Co Inc (LCI) United States $0.322B 2.99
CASI Pharmaceuticals (CASI) United States $0.310B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.306B 0.00
HARPOON THERAPT (HARP) United States $0.288B 0.00
Dermira (DERM) United States $0.288B 0.00
Karyopharm Therapeutics (KPTI) United States $0.287B 0.00
Mast Therapeutics (SVRA) United States $0.285B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.261B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.259B 9.60
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.250B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.244B 0.00
Tyme Technologies (TYME) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.232B 0.00
Aclaris Therapeutics (ACRS) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.227B 0.00
Aldeyra Therapeutics (ALDX) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
ElectroCore (ECOR) United States $0.215B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.213B 0.00
Molecular Templates (MTEM) United States $0.209B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
IMV INC (IMV) Canada $0.205B 0.00
Recro Pharma (REPH) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.196B 203.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.179B 0.00
Ocular Therapeutix (OCUL) United States $0.173B 0.00
Aquestive Therapeutics (AQST) United States $0.162B 0.00
Neon Therapeutics (NTGN) United States $0.159B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.155B 0.00
Cardiome Pharma (CORV) Canada $0.150B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.144B 0.00
China SXT Pharmaceuticals (SXTC) China $0.142B 0.00
MediWound (MDWD) Israel $0.141B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.128B 0.00
DURECT (DRRX) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Adherex Technologies (FENC) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.113B 0.00
Zafgen (ZFGN) United States $0.112B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
Natural Alternatives (NAII) United States $0.088B 8.63
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Otonomy (OTIC) United States $0.086B 0.00
Genocea Biosciences (GNCA) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.076B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.062B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
Capnia (SLNO) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
KemPharm (KMPH) United States $0.054B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.045B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
Achaogen (AKAO) United States $0.036B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.035B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
ContraFect (CFRX) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Xenetic Biosciences (XBIO) United States $0.021B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Shineco (TYHT) China $0.015B 2.60
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00